Staphylococcus schleiferi subsp. schleiferi is a coagulase-negative staphylococcus, usually present as a contaminant in human specimens. A near relative, S. schleiferi subsp. coagulans, possesses coagulase activity but has not been reported from humans. We here describe three isolates of pseudocoagulase-positive S. schleiferi subsp. schleiferi and one isolate of S. schkiferi subsp. coagulans from human patients. The pseudocoagulase from the S. schleiferi subsp. schleiferi isolates differs from S. aureus staphylocoagulase by being sensitive to a combination of protease inhibitors (aprotinin, N-ethylmaleimide, and heparin). These isolates could all easily be confused with S. aureus in a typical clinical laboratory, since they all possess a heat-stable DNase and promote clotting formation. Moreover, S. schkiferi subsp. coagulans produces protein A, and S. schleiferi subsp. schleiferi expresses a clumping factor (fibrinogen affinity factor). Southern blot hybridization with an S. aureus coa-specific probe revealed no sequence related to the coa gene in any of the S. schleiferi isolates, and their riboprobe profiles and biochemical characteristics were typical of S. schkeiferi subspecies, not of S. aureus. This study demonstrates that both subspecies of S. schleiferi can promote clotting of rabbit plasma in the standard tube test for coagulase.
Staphylococcal infections are frequent in humans and other mammals. Infections by Staphylococcus aureus can have serious consequences, particularly in hospitalized patients, and require aggressive antibiotic therapy, which carries the risk of adverse reactions. The therapeutic decision relies on rapid laboratory identification of the infectious agent, which usually involves evaluation of the production of coagulase, since S. aureus usually produces staphylocoagulase, whereas the less dangerous staphylococci are usually coagulase negative.
S. schleiferi subsp. schleiferi is a coagulase-negative staphylococcus which was described in 1988 (7) and which, although usually benign, has been associated with human conditions, such as infection of wounds, hip prostheses, or vascular devices, brain empyema, and bacteremia (6, 11, 13) . S. schleiferi subsp. schleiferi resembles S. aureus in that both species express a clumping factor (fibrinogen affinity factor) and produce a heat-stable DNase but differ in that only S. aureus produces staphylocoagulase. In 1990, a new subspecies, S. schleiferi subsp. coagulans, was obtained from strains isolated from the external auditory meatus of dogs suffering from external otitis (9) . S. schleiferi subsp. coagulans is coagulase tube test positive, produces betahemolysin and a heat-stable nuclease but not a clumping factor, and has not previously been isolated from humans.
Staphylocoagulase reacts specifically with prothrombin, resulting in the formation of staphylothrombin, which has specific proteolytic activity and is resistant to natural thrombin inhibitors, such as heparin (18) . As S. aureus does not grow in coagulase plasma, the tube test involves a delay of 2 to 4 h, and more time is rarely needed (17) .
Some staphylococci can give false-positive reactions in the coagulase tube test through their production of proteases (pseudocoagulases) capable of digesting prothrombin and/or plasminogen and thereby promoting clotting in the absence of staphylocoagulase. This pseudocoagulase activity, but not staphylocoagulase activity, is inhibited by the addition of a combination of anticoagulants and protease inhibitors to the rabbit plasma substrate (19) . Chomarat and Flandrois (4) achieved satisfactory inhibition of nonspecific clotting in the presence of EDTA, aprotinin, N-ethylmaleimide, and heparin.
We report on three coagulase tube test-positive isolates of S. schleiferi subsp. schleiferi from two different patients. These isolates also expressed a clumping factor (fibrinogen affinity factor) and a heat-stable DNase and could have been misidentified as S. aureus. Clotting activity was inhibited by a combination of protease inhibitors and anticoagulants, indicating the presence of a pseudocoagulase. Another coagulase-positive isolate from another patient was identified as S. schleiferi subsp. coagulans; its coagulase activity remained in the presence of inhibitors.
None of the four isolates and neither of two S. schleiferi subsp. coagulans reference strains contained DNA that could hybridize to an S. aureus coagulase gene (coa)-specific probe at a high stringency. The identity of the S. schleiferi isolates was confirmed by their biochemical profiles (6, 7) and by ribotyping (8 Reference and control strains were S. schleiferi subsp. schleiferi ATCC 43808 (7), S. schleiferi subsp. coagulans GA211 (JCM 7470) and GA64 (9), and S. aureus 83254, from which the coagulase gene has been cloned and sequenced (15) ( Table 1) . A series of S. schleiferi subsp. schleiferi isolates were included for ribotyping; together with ATCC 43808, these isolates represented the six characteristic ribotypes of this subspecies (8) (15) . Plasmid pKK3535, a pBR322 derivative containing the rnB ribosomal operon of Eschenichia coli, encoding 5S, 16S, and 23S RNAs and tRNAGlU (3), was used as the probe specific for genes coding for rRNA as described previously (8) . The probes were labelled with digoxigenin-11-dUTP by random priming according to the manufacturer's instructions (Boehringer).
Hybridization. Hybridization was performed under stringent conditions and detected with the DIG kit (Boehringer) according to the manufacturer's instructions. Chemiluminescence was generated by hydrolysis of the Lumigen PPD substrate [4- 
RESULTS
The phenotypic characteristics permitting the identification of the three isolates as S. schleiferi subsp. schleiferi and the fourth as S. schleifeni subsp. coagulans are listed in Table 2 . The two subspecies differ in that S. schleifeni subsp. coagulans possesses protein A (a characteristic not mentioned by Igimi and colleagues [9] ) and produces urease but lacks clumping factor. Both subspecies differ from S. aureus in their inability to ferment maltose, lactose, mannitol, sucrose, or turanose. Confusion between the S. schleiferi subspecies with clotting activity and S. aureus is conceivable, since they all possess heat-stable DNases. Furthermore, S. schleiferi subsp. coagulans possesses protein A and urease activity, while S. schleiferi subsp. schleiferi expresses clumping factor ( 
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those already described for S. schleifen (Fig. 1) . All strains coagulans GA64, suggesting that its clotting activity was due displayed the three HindIII bands in the size range of 1.6 to to pseudocoagulase. 2 kb that are present in all S. schleifen strains (8) but are also Southern blot analysis of genomic DNA was performed on found in S. intennedius (10) . Isolates N920213 and N920235 these strains with a coagulase gene-specific probe. A single (both from patient 1) and N920246 (from patient 2) showed patterns identical to those of ATCC 43808 (ribotype A) and isolate N860346 (ribotype C), respectively. On the contrary, our isolate of S. schleifen subsp. coagulans (N920247; patient 3) as well as the two type strains (GA211 and GA64) displayed patterns that were not encountered previously in S. schleiferi. The degree of similarity between these patterns showed that the S. schleifen subsp. coagulans patterns were not closer to each other (56 to 67% similarity) than they were to those of S. schleiferi subsp. schleiferi (44 to 67% similarity) (Table 4) . Additionally, the degree of similarity between the different patterns of S. schleiferi subsp. schleiferi can be as low as 44% ( Table 4 ), suggesting that ribotyping cannot differentiate between strains at the subspecies level. DISCUSSION S. aureus, unlike most other staphylococci, is a major human pathogen, and its isolation from a patient is usually a signal for aggressive antibiotic therapy, with its attendant risks. In routine laboratory practice, the production of coagulase is frequently used as a criterion to distinguish S. aureus from other staphylococci, since other coagulasepositive staphylococcal species, such as S. hyicus, S. intermedius, or S. schleiferi subsp. coagulans, have not until now been found in humans (9, 12) . Other S. aureus characteristics, such as the presence of a fibrinogen affinity factor or a heat-stable DNase, are useful for completing the identification of S. aureus but may be detected in S. lugdunensis or S. schleiferi subsp. schleiferi, both of which are responsible for human infections (6, 11, 13) . The two subspecies of S. schleiferi (schleifen and coagulans) both express a heatstable DNase, the former produces a fibrinogen affinity factor, and the later produces a coagulase (9) and protein A (this study).
We report four non-S. aureus human staphylococcal isolates giving positive results in the standard tube test for coagulase. Three of the isolates were identified as S. schleiferi subsp. schleiferi, and their presence was not clinically significant; the two patients resolved their infection without antibiotic therapy. The fourth isolate was identified as S. schleiferi subsp. coagulans, which had not previously been found in humans. The isolate appeared pathogenic in association with a group G streptococcal isolate. Both isolates were acquired in circumstances suggesting nosocomial transmission, and the patient received antibiotic treatment.
The staphylocoagulase produced by S. aureus may be differentiated from the proteases giving pseudocoagulase activity by the addition of anticoagulants and protease inhibitors to the plasma substrate in the coagulase tube test. The EDTA present in the standard tube test is not sufficient to inhibit certain proteases capable of pseudocoagulase activity, as reported for two of the three types of proteases Ribotyping did not accurately separate the two subspecies into two distinct groups of related ribotypes. Indeed, if all the ribotypes observed clearly belong to the S. schleiferi group, as assessed by the presence of a number of common bands (8) , the ribotypes of the S. schleiferi subsp. schleiferi strains were not more related to each other (44 to 89% similarity) than they were to the ribotypes of the three S. schleiferi subsp. coagulans strains (44 to 67% similarity) (Table 4 ). This result may reflect the failure of ribotyping in subspecies delineation. Alternatively, this result may reflect a higher relatedness between these subspecies than was previously expected. This hypothesis is supported by the observation of Igimi et al. (9) that the level of DNA-DNA relatedness between S. schleiferi subsp. schleiferi and S. schleiferi subsp. coagulans can be as high (73%) as the lowest level of relatedness between different strains of S. schleiferi subsp. coagulans (72%).
Finally, the incidence of isolation of non-S. aureus staphylococci expressing coagulase activity, a fibrinogen affinity factor, and a heat-stable DNase could be underestimated, since these strains are probably sometimes misidentified as S. aureus, leading to overprescription of antibiotics. The nonacidification of maltose, mannitol, and lactose by S. schleiferi subsp. schleiferi or S. schleiferi subsp. coagulans could help in recognizing these strains in routine laboratory practice.
